Literature DB >> 1384048

mu-crystallin is a mammalian homologue of Agrobacterium ornithine cyclodeaminase and is expressed in human retina.

R Y Kim1, R Gasser, G J Wistow.   

Abstract

mu-Crystallin is the major component of the eye lens in several Australian marsupials. The complete sequence of kangaroo mu-crystallin has now been obtained by cDNA cloning. The predicted amino acid sequence shows similarity with ornithine cyclodeaminases encoded by the tumor-inducing (Ti) plasmids of Agrobacterium tumefaciens. Until now, neither ornithine cyclodeaminase nor any structurally related enzymes have been observed in eukaryotes. RNA analysis of kangaroo tissues shows that mu-crystallin is expressed at high abundance in lens, but outside the lens mu-crystallin is preferentially expressed in neural tissues, retina, and brain. An almost full-length cDNA for mu-crystallin was cloned from human retina. In human tissues, mu-crystallin mRNA is present in neural tissue, muscle, and kidney. This pattern of expression and relationship to an enzyme involved in unusual amino acid metabolism suggests the interesting possibility that mammalian mu-crystallins could be enzymes participating in processes such as osmoregulation or the metabolism of excitatory amino acids.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1384048      PMCID: PMC50112          DOI: 10.1073/pnas.89.19.9292

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

Review 1.  Stein and Moore Award address. Reconstructing history with amino acid sequences.

Authors:  R F Doolittle
Journal:  Protein Sci       Date:  1992-02       Impact factor: 6.725

2.  Evolution of a protein superfamily: relationships between vertebrate lens crystallins and microorganism dormancy proteins.

Authors:  G Wistow
Journal:  J Mol Evol       Date:  1990-02       Impact factor: 2.395

3.  The recruitment of crystallins: new functions precede gene duplication.

Authors:  J Piatigorsky; G Wistow
Journal:  Science       Date:  1991-05-24       Impact factor: 47.728

4.  Lens protein expression in mammals: taxon-specificity and the recruitment of crystallins.

Authors:  G Wistow; H Kim
Journal:  J Mol Evol       Date:  1991-03       Impact factor: 2.395

5.  A single base pair change in proline biosynthesis genes causes osmotic stress tolerance.

Authors:  A M Dandekar; S L Uratsu
Journal:  J Bacteriol       Date:  1988-12       Impact factor: 3.490

6.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

7.  The Noc region of Ti plasmid C58 codes for arginase and ornithine cyclodeaminase.

Authors:  N Sans; G Schröder; J Schröder
Journal:  Eur J Biochem       Date:  1987-08-17

8.  Aldehyde dehydrogenase from human liver. Primary structure of the cytoplasmic isoenzyme.

Authors:  J Hempel; H von Bahr-Lindström; H Jörnvall
Journal:  Eur J Biochem       Date:  1984-05-15

9.  Ornithine cyclodeaminase from Ti plasmid C58: DNA sequence, enzyme properties and regulation of activity by arginine.

Authors:  N Sans; U Schindler; J Schröder
Journal:  Eur J Biochem       Date:  1988-04-05

10.  Tau-crystallin/alpha-enolase: one gene encodes both an enzyme and a lens structural protein.

Authors:  G J Wistow; T Lietman; L A Williams; S O Stapel; W W de Jong; J Horwitz; J Piatigorsky
Journal:  J Cell Biol       Date:  1988-12       Impact factor: 10.539

View more
  22 in total

1.  The plant oncogene rolD encodes a functional ornithine cyclodeaminase.

Authors:  M Trovato; B Maras; F Linhares; P Costantino
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-30       Impact factor: 11.205

2.  Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia.

Authors:  Frank A Middleton; Karoly Mirnics; Joseph N Pierri; David A Lewis; Pat Levitt
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

3.  Quantitative assessment of transcriptome differences between brain territories.

Authors:  Michel de Chaldée; Marie-Claude Gaillard; Nicolas Bizat; Jean-Marie Buhler; Olivier Manzoni; Joël Bockaert; Philippe Hantraye; Emmanuel Brouillet; Jean-Marc Elalouf
Journal:  Genome Res       Date:  2003-07       Impact factor: 9.043

4.  Insights into Enzyme Catalysis and Thyroid Hormone Regulation of Cerebral Ketimine Reductase/μ-Crystallin Under Physiological Conditions.

Authors:  André Hallen; Arthur J L Cooper; Joanne F Jamie; Peter Karuso
Journal:  Neurochem Res       Date:  2015-05-01       Impact factor: 3.996

5.  Identification of CRYM as a candidate responsible for nonsyndromic deafness, through cDNA microarray analysis of human cochlear and vestibular tissues.

Authors:  Satoko Abe; Toyomasa Katagiri; Akihiko Saito-Hisaminato; Shin-ichi Usami; Yasuhiro Inoue; Tatsuhiko Tsunoda; Yusuke Nakamura
Journal:  Am J Hum Genet       Date:  2002-12-06       Impact factor: 11.025

6.  Crystal structure of human micro-crystallin complexed with NADPH.

Authors:  Zhongjun Cheng; Lihua Sun; Jianhua He; Weimin Gong
Journal:  Protein Sci       Date:  2007-02       Impact factor: 6.725

7.  CRYM mutations cause deafness through thyroid hormone binding properties in the fibrocytes of the cochlea.

Authors:  A Oshima; S Suzuki; Y Takumi; K Hashizume; S Abe; S Usami
Journal:  J Med Genet       Date:  2006-06       Impact factor: 6.318

8.  The novel genetic disorder microhydranencephaly maps to chromosome 16p13.3-12.1.

Authors:  G N Kavaslar; S Onengüt; O Derman; A Kaya; A Tolun
Journal:  Am J Hum Genet       Date:  2000-04-04       Impact factor: 11.025

9.  Analysis of chaperone mRNA expression in the adult mouse brain by meta analysis of the Allen Brain Atlas.

Authors:  Andrew T N Tebbenkamp; David R Borchelt
Journal:  PLoS One       Date:  2010-10-28       Impact factor: 3.240

Review 10.  Reciprocal Control of Thyroid Binding and the Pipecolate Pathway in the Brain.

Authors:  André Hallen; Arthur J L Cooper
Journal:  Neurochem Res       Date:  2016-08-12       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.